CI - Cigna Corporation

NYSE - NYSE Delayed Price. Currency in USD
202.23
+0.90 (+0.45%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close201.33
Open202.14
Bid181.15 x 800
Ask209.50 x 800
Day's Range197.41 - 203.06
52 Week Range163.02 - 227.13
Volume3,695,654
Avg. Volume2,527,822
Market Cap49.216B
Beta0.85
PE Ratio (TTM)19.72
EPS (TTM)10.26
Earnings DateNov 1, 2018
Forward Dividend & Yield0.04 (0.02%)
Ex-Dividend Date2018-03-09
1y Target Est225.61
Trade prices are not sourced from all markets
  • Moody's21 hours ago

    Halfmoon Parent, Inc. -- Moody's assigns a P-2 commercial paper rating to Halfmoon Parent, Inc.

    Rating Action: Moody's assigns a P-2 commercial paper rating to Halfmoon Parent, Inc. New York, September 21, 2018 -- Moody's Investors Service (Moody's) has assigned a Prime-2 short term rating, on review for downgrade, to the commercial paper (CP) program of Halfmoon Parent, Inc. (Halfmoon), a wholly owned subsidiary of Cigna Corporation (Cigna, Baa1 on review for downgrade). This is consistent with Moody's rating of Cigna's short-term commercial paper.

  • InvestorPlace21 hours ago

    Cigna’s Merger With Express Scripts Is Positive for Cigna Stock

    Federal officials finally approved the merger of Cigna (NYSE:CI), one of the nation’s biggest health insurers, and pharmacy benefit manager Express Scripts Holding Co. (NASDAQ:ESRX) Cigna stock has been a strong performer in recent years, and this merger will make CI stock even more formidable. One of the motivating factors behind this $52 billion deal was the desire to keep pace with Aetna (NYSE:AET), Cigna’s chief rival in the health insurance market. Aetna is planning to join forces with CVS Health (NYSE:CVS), the drugstore chain that competes with Express Scripts in most of the largest regional markets.

  • See what the IHS Markit Score report has to say about Cigna Corp.
    Markit2 days ago

    See what the IHS Markit Score report has to say about Cigna Corp.

    This could indicate that investors who seek to profit from falling equity prices are not currently targeting CI. Over the last month, growth of ETFs holding CI is favorable, with net inflows of $16.69 billion.

  • Department of Justice Approves Cigna-Express Scripts Deal
    GuruFocus.com4 days ago

    Department of Justice Approves Cigna-Express Scripts Deal

    Clearing a major hurdle in the health care space's path to consolidation, Cigna Corp. (CI) announced on Monday its $52 billion acquisition of Express Scripts Holding Co. (ESRX) was approved by the U.S. Department of Justice, sending shares higher in after-hours trading. Warning! GuruFocus has detected 3 Warning Signs with AVGO. By combining the Bloomfield, Connecticut-based health insurer and the St. Louis-based pharmacy benefits manager, Tim Wentworth, president and CEO of Express Scripts, said the companies hope to "transform" health care by reducing costs, expanding choice and improving patient outcomes.

  • Cigna Moves Closer to Express Scripts Buyout With DoJ Nod
    Zacks4 days ago

    Cigna Moves Closer to Express Scripts Buyout With DoJ Nod

    Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.

  • 8 GARP Stocks to Scoop Up for Maximum Returns
    Zacks4 days ago

    8 GARP Stocks to Scoop Up for Maximum Returns

    If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

  • Business Wire4 days ago

    Cigna Expands Personalized Diabetes Prevention Program in Collaboration with Omada Health

    Global health service company Cigna (NYSE: CI) is expanding its Diabetes Prevention Program (DPP) in collaboration with Omada Health. The new program is designed to deliver an expanded suite of personalized, user-friendly digital health tools to help people prevent the onset of diabetes and other chronic diseases, and will be available to Cigna's national and regional employer clients effective January 2019. Using the digital lifestyle program, participants enrolled in a Cigna-administered health plan may be empowered to make impactful and sustainable behavior changes under the guidance of a personal health coach and with the support from a peer group.

  • Cigna deal gets antitrust nod, positive sign for CVS/Aetna
    Reuters5 days ago

    Cigna deal gets antitrust nod, positive sign for CVS/Aetna

    The decision bodes well for the pending U.S. antitrust review of CVS Health Corp's (CVS.N) proposed $69 billion acquisition of health insurer Aetna Inc (AET.N). The new company will marry Cigna's business of managing health plans for corporations and the government with Express Scripts' (ESRX.O) role handling pharmacy benefits for those same customers.

  • Cigna deal gets antitrust nod, positive sign for CVS/Aetna
    Reuters5 days ago

    Cigna deal gets antitrust nod, positive sign for CVS/Aetna

    The decision bodes well for the pending U.S. antitrust review of CVS Health Corp's (CVS.N) proposed $69 billion acquisition of health insurer Aetna Inc (AET.N). The new company will marry Cigna's business of managing health plans for corporations and the government with Express Scripts' (ESRX.O) role handling pharmacy benefits for those same customers.

  • Cigna deal gets antitrust nod, positive sign for CVS-Aetna
    Reuters5 days ago

    Cigna deal gets antitrust nod, positive sign for CVS-Aetna

    The decision bodes well for the pending U.S. antitrust review of CVS Health Corp's (CVS.N) proposed $69 billion acquisition of health insurer Aetna Inc (AET.N). The new company will marry Cigna's business of managing health plans for corporations and the government with Express Scripts' (ESRX.O) role handling pharmacy benefits for those same customers.

  • Congratulations, Cigna! Now Comes the Hard Part.
    Bloomberg5 days ago

    Congratulations, Cigna! Now Comes the Hard Part.

    Cigna Corp. has successfully dodged two giant obstacles in its attempt to purchase pharmacy-benefit manager Express Scripts Holding Co. First, it got past Carl Icahn, who tried to convince investors to vote no on the deal in August, only to drop the effort days later after giving it further thought.

  • MarketWatch5 days ago

    DOJ has cleared the Cigna-Express Scripts deal

    The U.S. Department of Justice has cleared health insurer Cigna Corp.'s $54 billion plan to buy the pharmacy-benefit manager Express Scripts Holding Co. [c: ESRX], the companies said on Monday. The companies said they have also been cleared by departments of insurance in 16 states and are working with regulators in other states. If the deal's closing conditions are met, the companies said that they expect the acquisition to close by the end of the year. Express Scripts shares surged 4% in Monday afternoon trade, and Cigna shares rose nearly 2%, compared with a 0.5% slump in the S&P 500 and a 0.3% decline in the Dow Jones Industrial Average .

  • Cigna-Express Scripts Deal Is Cleared by U.S. Justice Department
    Bloomberg5 days ago

    Cigna-Express Scripts Deal Is Cleared by U.S. Justice Department

    Antitrust enforcers signed off on Cigna Corp.’s $54 billion takeover of pharmacy-benefit manager Express Scripts Holding Co., clearing one of two health-care deals that stand to reshape the industry. Approval by the Justice Department smooths the way for the deal to wrap up by the end of the year, the companies said Monday in a joint statement. Express Scripts shares rose 3.7 percent to $95.23 at the close in New York.

  • CNBC5 days ago

    DOJ clears Cigna's acquisition of Express Scripts

    The U.S. Department of Justice has cleared Cigna's acquisition of Express Scripts, the companies announced in a statement Monday. Shareholders voted to approve the merger last month, despite opposition from activist investor Carl Icahn. The U.S. Department of Justice has cleared Cigna CI 's $52 billion acquisition of Express Scripts ESRX , the companies announced in a statement Monday.

  • Business Wire5 days ago

    U.S. Department of Justice Grants Clearance to Cigna’s Acquisition of Express Scripts

    Cigna Corporation (CI) (“Cigna”) and Express Scripts Holding Company (ESRX) (“Express Scripts”) today announced that the Antitrust Division of the United States Department of Justice (DOJ) has cleared their pending merger, terminating the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. “We are pleased that the Department of Justice has cleared our transaction and that we are another step closer to completing our merger and delivering greater affordability, choice and predictability to our customers and clients as a combined company,” said David Cordani, President and Chief Executive Officer of Cigna. “Together, we believe we will be able to do even more to reduce healthcare costs, expand choice, and improve patient outcomes,” said Tim Wentworth, President and Chief Executive Officer of Express Scripts.

  • Barrons.com8 days ago

    Watch Health Care and Autos for Signs of Trouble, BAML Says

    The health-care and auto sectors have the potential to be trouble spots as the economy heads towards its next recession, according to strategists at Bank of America Merrill Lynch.

  • Business Wire8 days ago

    Cigna Foundation Donates $100,000 to American Red Cross for Hurricane Florence Relief

    The Cigna Foundation is donating $100,000 to the American Red Cross for Hurricane Florence relief efforts and will match Cigna employee donations made to the American Red Cross and other certified organizations. “Our hearts go out to everyone in the affected areas and we are committed to supporting the relief efforts of the American Red Cross and other organizations. Working together with national and local relief organizations, we hope to help make this difficult time easier for all those impacted,” said Mary Engvall, executive director of the Cigna Foundation.

  • ACCESSWIRE8 days ago

    Today's Research Reports on Trending Tickers: Boston Scientific and Cigna

    “Markets today are moving primarily on China trade [and] tariff news,” according to Mark Esposito, chief executive of Esposito Securities in Dallas. Boston Scientific's stock jumped 3.24% Thursday, to close the day at $37.62. The stock recorded a trading volume of 14,332,530 shares, which was above its three months average volume of 6,591,750 shares.

  • PR Newswire9 days ago

    Crain's Custom Media And Cigna Announce Illinois' Healthiest Employers For 2018

    CHICAGO, Sept.13, 2018 /PRNewswire/ -- Crain's Custom Media, a division of Crain's Chicago Business, and Cigna (CI) announce the winners of the 2018 Illinois' Healthiest Employers Awards, recognizing companies that make workplace wellness a priority. The 7th annual awards were presented at a ceremony yesterday at the MB Ice Arena by Chicago Blackhawks Ambassador and NHL Hall of Famer Denis Savard. This is the third year of Cigna's sponsorship of the Illinois' Healthiest Employers Awards, a corporate wellness program that encourages healthier lifestyles through biometric, fitness, nutrition and other health-related educational advice that emphasize preventing illness and prolonging life.

  • As market pressures loom, healthcare giant Cigna launches a $250 million venture fund
    TechCrunch10 days ago

    As market pressures loom, healthcare giant Cigna launches a $250 million venture fund

    If you don't think the healthcare market is prepping for the radical transformations that remote care, persistent diagnostics, as well as and monitoring and improving targeted treatments are going to bring to the industry, think again. Healthcare companies are steeling themselves for the shift in healthcare services in the most desperate way they can -- by launching venture funds. The latest to make the move is Cigna, the multi-billion-dollar healthcare insurer which is now launching a $250 million venture fund called Cigna Ventures.

  • Business Wire10 days ago

    Cigna Announces Cigna Ventures with $250 Million to Fund Transformative Innovation and Growth for Health Care

    Today, global health service company Cigna announced the launch of Cigna Ventures, a corporate venture fund focused on transformative and innovative health care companies.

  • The Wall Street Journal10 days ago

    [$$] Cigna Launches First Venture Fund With $250 Million for Health Care

    Corp. has launched a venture-capital arm with $250 million for its debut fund. In the past few years, Cigna has invested roughly $100 million in digital health and health-care services startups including Omada Health Inc. and MDLive.

  • Bulls bet on Intel, this healthcare name
    CNBC Videos5 days ago

    Bulls bet on Intel, this healthcare name

    "Halftime Report" trader Pete Najarian spots unusual options activity in shares of Intel and Cigna.